OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration

Figure 3

Prognostic analysis of OSM in ccRCC. Kaplan-Meier survival analysis method to compare the differences in (a) overall survival and (b) disease-specific survival prognostic indicators between the OSM high and low expression groups in the TCGA database ( value < 0.05). (c) Integration of OSM expression and clinicopathological parameters from the TCGA database to construct a nomogram survival prediction system to predict 1-, 3-, and 5-year survival rates in ccRCC patients. (d) Plotting nomogram prediction system calibration curves to assess patient prognostic predictive ability.

(a)

(b)

(c)

(d)